Longeveron (LGVN) Liabilities and Shareholders Equity (2021 - 2026)

Longeveron (LGVN) recorded quarterly Liabilities and Shareholders Equity of $21.2 million in Q1 2026, up 106.7% quarter-over-quarter from $10.3 million in Q4 2025, and up 1.74% on a YoY basis from $20.8 million in Q1 2025.

Longeveron (LGVN) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Longeveron's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $21.2 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 1.74% year-over-year to $21.2 million; the TTM figure through Mar 2026 stood at $63.8 million (down 33.36% YoY), while the FY2025 annual figure was $10.3 million, down 59.85% from the prior year.
  • Liabilities and Shareholders Equity was $21.2 million for Q1 2026 at Longeveron, up from $10.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $29.9 million in Q3 2024 to a low of $9.7 million in Q1 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $18.5 million across 5 years, with a median of $18.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity soared 157.28% in 2024, then sank 59.85% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $27.4 million in 2022, then tumbled by 55.94% to $12.1 million in 2023, then soared by 111.61% to $25.6 million in 2024, then tumbled by 59.85% to $10.3 million in 2025, then jumped by 106.7% to $21.2 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $21.2 million (Q1 2026), $10.3 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 21.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.21 Mn
Dec 31, 2025 10.26 Mn
Sep 30, 2025 15.56 Mn
Jun 30, 2025 16.75 Mn
Mar 31, 2025 20.85 Mn
Dec 31, 2024 25.56 Mn
Sep 30, 2024 29.91 Mn
Jun 30, 2024 19.39 Mn
Mar 31, 2024 9.70 Mn
Dec 31, 2023 12.08 Mn
Sep 30, 2023 11.63 Mn
Jun 30, 2023 17.09 Mn
Mar 31, 2023 21.81 Mn
Dec 31, 2022 27.41 Mn
Dec 31, 2021 42.77 Mn